ZTS
NYSE Zoetis, Inc. Class A$71.75 ↑ +0.42 (+0.59%) Trading Up from the previous close of $71.33, $0.34 below the day’s high of $72.09
- YTD change
- -42.98%
- vs 20-day SMA
- +0.08%
- vs 200-day SMA
- -26.67%
Price ranges
Price & Performance
-45.47 (-38.93%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 71.2% away from all-time highs of $249.27
- ZTS is down 43% since the beginning of the year
- ZTS is down 50% over the past 12 months
- ZTS is down 2% over the past 1 month
- 4% of all ZTS investors are betting against ZTS
- Number of investors short ZTS has gone down 11% versus last month
ZTS reads neutral: price sits above one of the two key moving averages, short interest is falling month over month, the 12-month move is -50.0%.
- Previous minute
- -$0.02
- Last hour
- +$0.31
- Last 5 days
- +2.06%
- vs 8-day SMA
- +1.74%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.